We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Arcera and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Latest News
Stay up-to-date with Arcera’s most recent updates.
Arcera Life Sciences and Daewoong Expand Strategic Partnership to Bring Enavogliflozin to...
Monday 29th June 2026
Expansion builds on successful collaboration across Latin America and reinforces commitment to advancing innovative cardiometabolic therapies across international markets.
M42 and Arcera Partner to Advance Biopharma Localization and Next Generation Life...
Wednesday 3rd June 2026
Abu Dhabi, UAE – June 03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, and...
Emirates Drug Establishment and Arcera Sign Agreement to Advance Pharmaceutical Manufacturing in...
Tuesday 5th May 2026
The partnership establishes a framework to strengthen local manufacturing, develop talent, and support long-term supply resilience. Abu Dhabi, United Arab...
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
Tuesday 28th April 2026
Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences...
Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate...
Tuesday 3rd February 2026
Held during the annual “UAE Innovates” month, which aims to reinforce the UAE’s position as an international beacon of innovation,...
Arcera Life Sciences Drives Healthcare Innovation with Strategic ISPOR UAE Chapter Partnership...
Saturday 31st January 2026
Signed during the ISPOR UAE Chapter 2026 Conference in Abu Dhabi, the Memorandum of Understanding (MoU) coincides with the launch...
Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia
Friday 16th January 2026
Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...
Arcera Life Sciences releases inaugural Sustainability Report
Thursday 18th December 2025
The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug...
Tuesday 10th June 2025
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Media contacts
Do you need to get in touch with us?
For media enquiries, contact our Global Communications team.
